Detact Diagnostics B.V.


ViroTact B.V. -


Mailing Address and Main Office

Hoge der A-3C

9712AC, Groningen

The Netherlands


Talk to us

We are nice people, let's get in touch. If you have any questions, requests or inquiries for us, just ask. We want to hear them.

Contact us mail


To help fight the global health pandemic caused by novel, pathogenic SARS-coronavirus 2, commonly known as COVID-19, ViroTact© is using innovative platform technology to develop a quick, easy to use, point of care test to identify COVID-19.

ViroTact© - CoviTact®

A key way the virus causes the infection is by a viral protease essential for infection.  


Our proprietary detection platform is ideally suited to developing a unique, quick and affordable test to detect infection by COVID-19 by detecting the presence of an essential virus-encoded protease in a patient sample.

How does CoviTact® work?

To use CoviTact®, collect a sample (e.g. sputum or other bodily fluid) suspected to contain COVID-19 particles. Before placing the sample in buffer, the ViroTact© near-infrared quenched substrate is added. If the essential virus-encoded protease is present, near-infrared light is emitted within minutes, which can be detected on a handheld near-infrared detector.

Specific and Sensitive testing

The ViroTact© substrate is specifically designed to interact with the COVID-19 protease. As the essential virus-encoded protease is highly specific and unique to this virus, the CoviTact® assay is highly specific for COVID-19.


Experience shows that the ViroTact© platform is sensitive, allowing the detection of very low levels of pathogens.


In short, ViroTact© - CoviTact® is an affordable, specific, quick, easy to use, point of care test.


CoviTact® promises to meet the urgent need for a simple test to address the current global pandemic situation.


For strategic & investment opportunities please contact:




The Netherlands: +31 6 15 39 17 48

UK: +44 7488 387774